Stock listing

Tokyo:4539 Nippon Chemiphar Co., Ltd. (日本ケミファ) 株価

Follow Nippon Chemiphar Co., Ltd. into a list and get an email when it puts out news.

Ticker: Tokyo:4539
Asset type: Stock
Sector: Health care
Industry: Pharmaceuticals
Exchange: Tokyo
Currency: JPY

What changed lately

Latest news release · Jan 15, 2026
Patient Enrollment Started for Phase IIa Clinical Trial on δ-Opioid Receptor Agonist NC-2800 in Patients with Depression.

Latest news

Patient Enrollment Started for Phase IIa Clinical Trial on δ-Opioid Receptor Agonist NC-2800 in Patients with Depression.

Jan 15, 2026

Notice Concerning Recording of Gain on Sales of Investment Securities (Extraordinary Income)

Jun 4, 2025

Notice of the 93rd Ordinary General Meeting of Shareholders.

May 26, 2025

Notice of the 91st Ordinary General Meeting of Shareholders.

May 29, 2023

All Nippon Chemiphar Co., Ltd. news

Decks

Q2 FY2022 Earnings Presentation
Earnings · 21 slides · Nov 14, 2022
Q2 FY2019 Earnings Presentation
Earnings · 19 slides · Nov 12, 2019

Nippon Chemiphar Co., Ltd. on 6ix

Sector: Health care
Industry: Pharmaceuticals
News releases: 1 in the last 12 months · 4 in all · newest Jan 15, 2026 · oldest 2023
Decks: 2 decks · latest Nov 14, 2022

Log in to ask 6ix AI your own questions about Nippon Chemiphar Co., Ltd.